Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Sequential TACE-SBRT Combined With Targeted Immunotherapy in Patients With Intermediate to Advanced Hepatocellular Carcinoma
Conditions
Locations
1
China
Nanfang Hosptial
Guangzhou, China
Start Date
September 1, 2024
Primary Completion Date
November 20, 2025
Completion Date
November 30, 2025
Last Updated
November 17, 2025
NCT07426094
NCT06987890
NCT07282184
NCT07285850
NCT07106827
NCT06999837
Lead Sponsor
Nanfang Hospital, Southern Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions